Literature DB >> 9875664

Absence of a directly causative role for human herpesvirus 7 in human lymphoma and a review of human herpesvirus 6 in human malignancy.

Z N Berneman1, G Torelli, M Luppi, R F Jarrett.   

Abstract

In search of a (new) viral etiological agent, we screened 64 lymph node samples from Hodgkin's disease (HD) and 43 samples (32 lymph node and 11 skin biopsies) from non-Hodgkin's lymphoma (NHL) for human herpesvirus 7 (HHV-7). Twenty-nine control samples were tested as well, including 17 with benign lymphadenopathy. None of the samples tested positive by Southern blot hybridization using HHV-7-specific probes. We conclude that there is no major HHV-7 load in human lymphoma and that HHV-7 is not likely to be directly involved in its etiology. This is in contrast to a small minority of human lymphoproliferative diseases in which HHV-6 can be found at high copy number, but in which an etiological role is still uncertain.

Entities:  

Mesh:

Year:  1998        PMID: 9875664     DOI: 10.1007/s002770050457

Source DB:  PubMed          Journal:  Ann Hematol        ISSN: 0939-5555            Impact factor:   3.673


  4 in total

Review 1.  Infectious agents in cutaneous T-cell lymphoma.

Authors:  Ezra D Mirvish; Rebecca G Pomerantz; Larisa J Geskin
Journal:  J Am Acad Dermatol       Date:  2010-08-07       Impact factor: 11.527

2.  Preferential associations of alleles of three distinct genes argue for the existence of two prototype variants of human herpesvirus 7.

Authors:  M Franti; J T Aubin; A Gautheret-Dejean; I Malet; A Cahour; J M Huraux; H Agut
Journal:  J Virol       Date:  1999-11       Impact factor: 5.103

3.  Real-time PCR for quantification of human herpesvirus 6 DNA from lymph nodes and saliva.

Authors:  S Collot; B Petit; D Bordessoule; S Alain; M Touati; F Denis; S Ranger-Rogez
Journal:  J Clin Microbiol       Date:  2002-07       Impact factor: 5.948

4.  Measles virus: evidence of an association with Hodgkin's disease.

Authors:  D Benharroch; Y Shemer-Avni; Y-Y Myint; A Levy; E Mejirovsky; I Suprun; Y Shendler; I Prinsloo; S Ariad; B Rager-Zisman; M Sacks; J Gopas
Journal:  Br J Cancer       Date:  2004-08-02       Impact factor: 7.640

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.